Industry Research Reports

Home > Reports > Pharma & Healthcare > Healthcare Contract Research Organization- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Healthcare Contract Research Organization- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-11-19

Pages: 113 Pages

Report ld: 3381759

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Healthcare Contract Research Organization was estimated to be worth US$ 71460 million in 2023 and is forecast to a readjusted size of US$ 126620 million by 2030 with a CAGR of 8.6% during the forecast period 2024-2030.

A Contract Research Organization (CRO) is a company that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of outsourced research services. These services can range across various stages of the drug development process, including preclinical research, clinical trials, regulatory affairs, data management, and market analysis. CROs offer their expertise to help these industries develop and commercialize new drugs, therapies, and medical devices, often by managing or conducting the clinical trials that are required by regulatory agencies before a product can enter the market.

Healthcare Contract Research Organization Market Size

M= millions and B=billions

The Contract Research Organization (CRO) market has been growing and evolving rapidly, influenced by changes in the pharmaceutical, biotech, and medical device industries. Here are the key trends shaping the CRO market:
Increased Outsourcing in Biopharma and Medical Device Sectors
Growing Demand for R&D Outsourcing: Pharmaceutical and biotech companies are increasingly outsourcing clinical trials and drug development tasks to CROs to reduce costs, speed up timelines, and gain access to specialized expertise.

Small and Mid-Sized Enterprises (SMEs): Smaller companies with limited resources, especially in the biotech sector, are using CRO services to manage their clinical and preclinical studies, focusing on their core research areas.

Decentralized Clinical Trials (DCTs): The COVID-19 pandemic accelerated the adoption of remote and decentralized trials, where CROs use technology like wearable devices, telemedicine, and remote monitoring to reduce patient site visits.

Hybrid Trials: Many CROs are now supporting hybrid trial models, where some trial elements are conducted on-site and others remotely, allowing greater flexibility in patient recruitment and retention.

Orphan Drugs and Personalized Medicine: CROs are focusing more on rare disease trials and personalized medicine, which require niche expertise and innovative trial designs. This focus is driven by advances in genetic and biomarker testing, which allow for more targeted treatment approaches.

Oncology: As one of the most active areas of clinical research, oncology continues to drive demand for CROs due to the complexity and duration of cancer trials and the need for innovative approaches in recruitment and data analysis.

Artificial Intelligence (AI) and Machine Learning (ML): CROs are leveraging AI and ML for predictive analytics, patient recruitment, and data analysis, enhancing efficiency and accuracy in clinical trials.

Digital Health Tools and Wearable Technology: Real-time data collection from wearables and other digital health devices allows CROs to monitor patient health remotely and continuously, reducing reliance on site visits and improving data quality.

The Healthcare Contract Research Organization market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Healthcare Contract Research Organization.

Market Segmentation

Report Metric
Details
Report Title
Healthcare Contract Research Organization- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 126620 million
CAGR(2024-2030)
8.6%
Market Size Available for Years
2019-2030
Global Healthcare Contract Research Organization Companies Covered
Labcorp, IQVIA, Syneos Health, Parexel, PRA, PPD, CRL, ICON, Wuxi Apptec, Medpace Holdings, Tigermed, Boji Medical Technology, Pharmaron
Global Healthcare Contract Research Organization Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Healthcare Contract Research Organization Market, Segment by Type
Preclinical CROs

Clinical CROs
Global Healthcare Contract Research Organization Market, Segment by Application
Pharmaceutical

Bio-pharm

Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Healthcare Contract Research Organization company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Healthcare Contract Research Organization in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Healthcare Contract Research Organization in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Healthcare Contract Research Organization Product Introduction
    1.2 Global Healthcare Contract Research Organization Market Size Forecast (2019-2030)
    1.3 Healthcare Contract Research Organization Market Trends & Drivers
        1.3.1 Healthcare Contract Research Organization Industry Trends
        1.3.2 Healthcare Contract Research Organization Market Drivers & Opportunity
        1.3.3 Healthcare Contract Research Organization Market Challenges
        1.3.4 Healthcare Contract Research Organization Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Healthcare Contract Research Organization Players Revenue Ranking (2023)
    2.2 Global Healthcare Contract Research Organization Revenue by Company (2019-2024)
    2.3 Key Companies Healthcare Contract Research Organization Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Healthcare Contract Research Organization Product Offered
    2.5 Key Companies Time to Begin Mass Production of Healthcare Contract Research Organization
    2.6 Healthcare Contract Research Organization Market Competitive Analysis
        2.6.1 Healthcare Contract Research Organization Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Healthcare Contract Research Organization Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare Contract Research Organization as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Preclinical CROs
        3.1.2 Clinical CROs
    3.2 Global Healthcare Contract Research Organization Sales Value by Type
        3.2.1 Global Healthcare Contract Research Organization Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Healthcare Contract Research Organization Sales Value, by Type (2019-2030)
        3.2.3 Global Healthcare Contract Research Organization Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Pharmaceutical
        4.1.2 Bio-pharm
        4.1.3 Other
    4.2 Global Healthcare Contract Research Organization Sales Value by Application
        4.2.1 Global Healthcare Contract Research Organization Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Healthcare Contract Research Organization Sales Value, by Application (2019-2030)
        4.2.3 Global Healthcare Contract Research Organization Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Healthcare Contract Research Organization Sales Value by Region
        5.1.1 Global Healthcare Contract Research Organization Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Healthcare Contract Research Organization Sales Value by Region (2019-2024)
        5.1.3 Global Healthcare Contract Research Organization Sales Value by Region (2025-2030)
        5.1.4 Global Healthcare Contract Research Organization Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Healthcare Contract Research Organization Sales Value, 2019-2030
        5.2.2 North America Healthcare Contract Research Organization Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Healthcare Contract Research Organization Sales Value, 2019-2030
        5.3.2 Europe Healthcare Contract Research Organization Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Healthcare Contract Research Organization Sales Value, 2019-2030
        5.4.2 Asia Pacific Healthcare Contract Research Organization Sales Value by Region (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Healthcare Contract Research Organization Sales Value, 2019-2030
        5.5.2 South America Healthcare Contract Research Organization Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Healthcare Contract Research Organization Sales Value, 2019-2030
        5.6.2 Middle East & Africa Healthcare Contract Research Organization Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Healthcare Contract Research Organization Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Healthcare Contract Research Organization Sales Value, 2019-2030
    6.3 United States
        6.3.1 United States Healthcare Contract Research Organization Sales Value, 2019-2030
        6.3.2 United States Healthcare Contract Research Organization Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Healthcare Contract Research Organization Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Healthcare Contract Research Organization Sales Value, 2019-2030
        6.4.2 Europe Healthcare Contract Research Organization Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Healthcare Contract Research Organization Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Healthcare Contract Research Organization Sales Value, 2019-2030
        6.5.2 China Healthcare Contract Research Organization Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Healthcare Contract Research Organization Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Healthcare Contract Research Organization Sales Value, 2019-2030
        6.6.2 Japan Healthcare Contract Research Organization Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Healthcare Contract Research Organization Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Healthcare Contract Research Organization Sales Value, 2019-2030
        6.7.2 South Korea Healthcare Contract Research Organization Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Healthcare Contract Research Organization Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Healthcare Contract Research Organization Sales Value, 2019-2030
        6.8.2 Southeast Asia Healthcare Contract Research Organization Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Healthcare Contract Research Organization Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Healthcare Contract Research Organization Sales Value, 2019-2030
        6.9.2 India Healthcare Contract Research Organization Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Healthcare Contract Research Organization Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Labcorp
        7.1.1 Labcorp Profile
        7.1.2 Labcorp Main Business
        7.1.3 Labcorp Healthcare Contract Research Organization Products, Services and Solutions
        7.1.4 Labcorp Healthcare Contract Research Organization Revenue (US$ Million) & (2019-2024)
        7.1.5 Labcorp Recent Developments
    7.2 IQVIA
        7.2.1 IQVIA Profile
        7.2.2 IQVIA Main Business
        7.2.3 IQVIA Healthcare Contract Research Organization Products, Services and Solutions
        7.2.4 IQVIA Healthcare Contract Research Organization Revenue (US$ Million) & (2019-2024)
        7.2.5 IQVIA Recent Developments
    7.3 Syneos Health
        7.3.1 Syneos Health Profile
        7.3.2 Syneos Health Main Business
        7.3.3 Syneos Health Healthcare Contract Research Organization Products, Services and Solutions
        7.3.4 Syneos Health Healthcare Contract Research Organization Revenue (US$ Million) & (2019-2024)
        7.3.5 Syneos Health Recent Developments
    7.4 Parexel
        7.4.1 Parexel Profile
        7.4.2 Parexel Main Business
        7.4.3 Parexel Healthcare Contract Research Organization Products, Services and Solutions
        7.4.4 Parexel Healthcare Contract Research Organization Revenue (US$ Million) & (2019-2024)
        7.4.5 Parexel Recent Developments
    7.5 PRA
        7.5.1 PRA Profile
        7.5.2 PRA Main Business
        7.5.3 PRA Healthcare Contract Research Organization Products, Services and Solutions
        7.5.4 PRA Healthcare Contract Research Organization Revenue (US$ Million) & (2019-2024)
        7.5.5 PRA Recent Developments
    7.6 PPD
        7.6.1 PPD Profile
        7.6.2 PPD Main Business
        7.6.3 PPD Healthcare Contract Research Organization Products, Services and Solutions
        7.6.4 PPD Healthcare Contract Research Organization Revenue (US$ Million) & (2019-2024)
        7.6.5 PPD Recent Developments
    7.7 CRL
        7.7.1 CRL Profile
        7.7.2 CRL Main Business
        7.7.3 CRL Healthcare Contract Research Organization Products, Services and Solutions
        7.7.4 CRL Healthcare Contract Research Organization Revenue (US$ Million) & (2019-2024)
        7.7.5 CRL Recent Developments
    7.8 ICON
        7.8.1 ICON Profile
        7.8.2 ICON Main Business
        7.8.3 ICON Healthcare Contract Research Organization Products, Services and Solutions
        7.8.4 ICON Healthcare Contract Research Organization Revenue (US$ Million) & (2019-2024)
        7.8.5 ICON Recent Developments
    7.9 Wuxi Apptec
        7.9.1 Wuxi Apptec Profile
        7.9.2 Wuxi Apptec Main Business
        7.9.3 Wuxi Apptec Healthcare Contract Research Organization Products, Services and Solutions
        7.9.4 Wuxi Apptec Healthcare Contract Research Organization Revenue (US$ Million) & (2019-2024)
        7.9.5 Wuxi Apptec Recent Developments
    7.10 Medpace Holdings
        7.10.1 Medpace Holdings Profile
        7.10.2 Medpace Holdings Main Business
        7.10.3 Medpace Holdings Healthcare Contract Research Organization Products, Services and Solutions
        7.10.4 Medpace Holdings Healthcare Contract Research Organization Revenue (US$ Million) & (2019-2024)
        7.10.5 Medpace Holdings Recent Developments
    7.11 Tigermed
        7.11.1 Tigermed Profile
        7.11.2 Tigermed Main Business
        7.11.3 Tigermed Healthcare Contract Research Organization Products, Services and Solutions
        7.11.4 Tigermed Healthcare Contract Research Organization Revenue (US$ Million) & (2019-2024)
        7.11.5 Tigermed Recent Developments
    7.12 Boji Medical Technology
        7.12.1 Boji Medical Technology Profile
        7.12.2 Boji Medical Technology Main Business
        7.12.3 Boji Medical Technology Healthcare Contract Research Organization Products, Services and Solutions
        7.12.4 Boji Medical Technology Healthcare Contract Research Organization Revenue (US$ Million) & (2019-2024)
        7.12.5 Boji Medical Technology Recent Developments
    7.13 Pharmaron
        7.13.1 Pharmaron Profile
        7.13.2 Pharmaron Main Business
        7.13.3 Pharmaron Healthcare Contract Research Organization Products, Services and Solutions
        7.13.4 Pharmaron Healthcare Contract Research Organization Revenue (US$ Million) & (2019-2024)
        7.13.5 Pharmaron Recent Developments

 8 Industry Chain Analysis
    8.1 Healthcare Contract Research Organization Industrial Chain
    8.2 Healthcare Contract Research Organization Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Healthcare Contract Research Organization Sales Model
        8.5.2 Sales Channel
        8.5.3 Healthcare Contract Research Organization Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Healthcare Contract Research Organization Market Trends
 Table 2. Healthcare Contract Research Organization Market Drivers & Opportunity
 Table 3. Healthcare Contract Research Organization Market Challenges
 Table 4. Healthcare Contract Research Organization Market Restraints
 Table 5. Global Healthcare Contract Research Organization Revenue by Company (2019-2024) & (US$ Million)
 Table 6. Global Healthcare Contract Research Organization Revenue Market Share by Company (2019-2024)
 Table 7. Key Companies Healthcare Contract Research Organization Manufacturing Base Distribution and Headquarters
 Table 8. Key Companies Healthcare Contract Research Organization Product Type
 Table 9. Key Companies Time to Begin Mass Production of Healthcare Contract Research Organization
 Table 10. Global Healthcare Contract Research Organization Companies Market Concentration Ratio (CR5 and HHI)
 Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare Contract Research Organization as of 2023)
 Table 12. Mergers & Acquisitions, Expansion Plans
 Table 13. Global Healthcare Contract Research Organization Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
 Table 14. Global Healthcare Contract Research Organization Sales Value by Type (2019-2024) & (US$ Million)
 Table 15. Global Healthcare Contract Research Organization Sales Value by Type (2025-2030) & (US$ Million)
 Table 16. Global Healthcare Contract Research Organization Sales Market Share in Value by Type (2019-2024)
 Table 17. Global Healthcare Contract Research Organization Sales Market Share in Value by Type (2025-2030)
 Table 18. Global Healthcare Contract Research Organization Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
 Table 19. Global Healthcare Contract Research Organization Sales Value by Application (2019-2024) & (US$ Million)
 Table 20. Global Healthcare Contract Research Organization Sales Value by Application (2025-2030) & (US$ Million)
 Table 21. Global Healthcare Contract Research Organization Sales Market Share in Value by Application (2019-2024)
 Table 22. Global Healthcare Contract Research Organization Sales Market Share in Value by Application (2025-2030)
 Table 23. Global Healthcare Contract Research Organization Sales Value by Region, (2019 VS 2023 VS 2030) & (US$ Million)
 Table 24. Global Healthcare Contract Research Organization Sales Value by Region (2019-2024) & (US$ Million)
 Table 25. Global Healthcare Contract Research Organization Sales Value by Region (2025-2030) & (US$ Million)
 Table 26. Global Healthcare Contract Research Organization Sales Value by Region (2019-2024) & (%)
 Table 27. Global Healthcare Contract Research Organization Sales Value by Region (2025-2030) & (%)
 Table 28. Key Countries/Regions Healthcare Contract Research Organization Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
 Table 29. Key Countries/Regions Healthcare Contract Research Organization Sales Value, (2019-2024) & (US$ Million)
 Table 30. Key Countries/Regions Healthcare Contract Research Organization Sales Value, (2025-2030) & (US$ Million)
 Table 31. Labcorp Basic Information List
 Table 32. Labcorp Description and Business Overview
 Table 33. Labcorp Healthcare Contract Research Organization Products, Services and Solutions
 Table 34. Revenue (US$ Million) in Healthcare Contract Research Organization Business of Labcorp (2019-2024)
 Table 35. Labcorp Recent Developments
 Table 36. IQVIA Basic Information List
 Table 37. IQVIA Description and Business Overview
 Table 38. IQVIA Healthcare Contract Research Organization Products, Services and Solutions
 Table 39. Revenue (US$ Million) in Healthcare Contract Research Organization Business of IQVIA (2019-2024)
 Table 40. IQVIA Recent Developments
 Table 41. Syneos Health Basic Information List
 Table 42. Syneos Health Description and Business Overview
 Table 43. Syneos Health Healthcare Contract Research Organization Products, Services and Solutions
 Table 44. Revenue (US$ Million) in Healthcare Contract Research Organization Business of Syneos Health (2019-2024)
 Table 45. Syneos Health Recent Developments
 Table 46. Parexel Basic Information List
 Table 47. Parexel Description and Business Overview
 Table 48. Parexel Healthcare Contract Research Organization Products, Services and Solutions
 Table 49. Revenue (US$ Million) in Healthcare Contract Research Organization Business of Parexel (2019-2024)
 Table 50. Parexel Recent Developments
 Table 51. PRA Basic Information List
 Table 52. PRA Description and Business Overview
 Table 53. PRA Healthcare Contract Research Organization Products, Services and Solutions
 Table 54. Revenue (US$ Million) in Healthcare Contract Research Organization Business of PRA (2019-2024)
 Table 55. PRA Recent Developments
 Table 56. PPD Basic Information List
 Table 57. PPD Description and Business Overview
 Table 58. PPD Healthcare Contract Research Organization Products, Services and Solutions
 Table 59. Revenue (US$ Million) in Healthcare Contract Research Organization Business of PPD (2019-2024)
 Table 60. PPD Recent Developments
 Table 61. CRL Basic Information List
 Table 62. CRL Description and Business Overview
 Table 63. CRL Healthcare Contract Research Organization Products, Services and Solutions
 Table 64. Revenue (US$ Million) in Healthcare Contract Research Organization Business of CRL (2019-2024)
 Table 65. CRL Recent Developments
 Table 66. ICON Basic Information List
 Table 67. ICON Description and Business Overview
 Table 68. ICON Healthcare Contract Research Organization Products, Services and Solutions
 Table 69. Revenue (US$ Million) in Healthcare Contract Research Organization Business of ICON (2019-2024)
 Table 70. ICON Recent Developments
 Table 71. Wuxi Apptec Basic Information List
 Table 72. Wuxi Apptec Description and Business Overview
 Table 73. Wuxi Apptec Healthcare Contract Research Organization Products, Services and Solutions
 Table 74. Revenue (US$ Million) in Healthcare Contract Research Organization Business of Wuxi Apptec (2019-2024)
 Table 75. Wuxi Apptec Recent Developments
 Table 76. Medpace Holdings Basic Information List
 Table 77. Medpace Holdings Description and Business Overview
 Table 78. Medpace Holdings Healthcare Contract Research Organization Products, Services and Solutions
 Table 79. Revenue (US$ Million) in Healthcare Contract Research Organization Business of Medpace Holdings (2019-2024)
 Table 80. Medpace Holdings Recent Developments
 Table 81. Tigermed Basic Information List
 Table 82. Tigermed Description and Business Overview
 Table 83. Tigermed Healthcare Contract Research Organization Products, Services and Solutions
 Table 84. Revenue (US$ Million) in Healthcare Contract Research Organization Business of Tigermed (2019-2024)
 Table 85. Tigermed Recent Developments
 Table 86. Boji Medical Technology Basic Information List
 Table 87. Boji Medical Technology Description and Business Overview
 Table 88. Boji Medical Technology Healthcare Contract Research Organization Products, Services and Solutions
 Table 89. Revenue (US$ Million) in Healthcare Contract Research Organization Business of Boji Medical Technology (2019-2024)
 Table 90. Boji Medical Technology Recent Developments
 Table 91. Pharmaron Basic Information List
 Table 92. Pharmaron Description and Business Overview
 Table 93. Pharmaron Healthcare Contract Research Organization Products, Services and Solutions
 Table 94. Revenue (US$ Million) in Healthcare Contract Research Organization Business of Pharmaron (2019-2024)
 Table 95. Pharmaron Recent Developments
 Table 96. Key Raw Materials Lists
 Table 97. Raw Materials Key Suppliers Lists
 Table 98. Healthcare Contract Research Organization Downstream Customers
 Table 99. Healthcare Contract Research Organization Distributors List
 Table 100. Research Programs/Design for This Report
 Table 101. Key Data Information from Secondary Sources
 Table 102. Key Data Information from Primary Sources
 Table 103. Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Healthcare Contract Research Organization Product Picture
 Figure 2. Global Healthcare Contract Research Organization Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 3. Global Healthcare Contract Research Organization Sales Value (2019-2030) & (US$ Million)
 Figure 4. Healthcare Contract Research Organization Report Years Considered
 Figure 5. Global Healthcare Contract Research Organization Players Revenue Ranking (2023) & (US$ Million)
 Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Healthcare Contract Research Organization Revenue in 2023
 Figure 7. Healthcare Contract Research Organization Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 8. Preclinical CROs Picture
 Figure 9. Clinical CROs Picture
 Figure 10. Global Healthcare Contract Research Organization Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
 Figure 11. Global Healthcare Contract Research Organization Sales Value Market Share by Type, 2023 & 2030
 Figure 12. Product Picture of Pharmaceutical
 Figure 13. Product Picture of Bio-pharm
 Figure 14. Product Picture of Other
 Figure 15. Global Healthcare Contract Research Organization Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
 Figure 16. Global Healthcare Contract Research Organization Sales Value Market Share by Application, 2023 & 2030
 Figure 17. North America Healthcare Contract Research Organization Sales Value (2019-2030) & (US$ Million)
 Figure 18. North America Healthcare Contract Research Organization Sales Value by Country (%), 2023 VS 2030
 Figure 19. Europe Healthcare Contract Research Organization Sales Value, (2019-2030) & (US$ Million)
 Figure 20. Europe Healthcare Contract Research Organization Sales Value by Country (%), 2023 VS 2030
 Figure 21. Asia Pacific Healthcare Contract Research Organization Sales Value, (2019-2030) & (US$ Million)
 Figure 22. Asia Pacific Healthcare Contract Research Organization Sales Value by Region (%), 2023 VS 2030
 Figure 23. South America Healthcare Contract Research Organization Sales Value, (2019-2030) & (US$ Million)
 Figure 24. South America Healthcare Contract Research Organization Sales Value by Country (%), 2023 VS 2030
 Figure 25. Middle East & Africa Healthcare Contract Research Organization Sales Value, (2019-2030) & (US$ Million)
 Figure 26. Middle East & Africa Healthcare Contract Research Organization Sales Value by Country (%), 2023 VS 2030
 Figure 27. Key Countries/Regions Healthcare Contract Research Organization Sales Value (%), (2019-2030)
 Figure 28. United States Healthcare Contract Research Organization Sales Value, (2019-2030) & (US$ Million)
 Figure 29. United States Healthcare Contract Research Organization Sales Value by Type (%), 2023 VS 2030
 Figure 30. United States Healthcare Contract Research Organization Sales Value by Application (%), 2023 VS 2030
 Figure 31. Europe Healthcare Contract Research Organization Sales Value, (2019-2030) & (US$ Million)
 Figure 32. Europe Healthcare Contract Research Organization Sales Value by Type (%), 2023 VS 2030
 Figure 33. Europe Healthcare Contract Research Organization Sales Value by Application (%), 2023 VS 2030
 Figure 34. China Healthcare Contract Research Organization Sales Value, (2019-2030) & (US$ Million)
 Figure 35. China Healthcare Contract Research Organization Sales Value by Type (%), 2023 VS 2030
 Figure 36. China Healthcare Contract Research Organization Sales Value by Application (%), 2023 VS 2030
 Figure 37. Japan Healthcare Contract Research Organization Sales Value, (2019-2030) & (US$ Million)
 Figure 38. Japan Healthcare Contract Research Organization Sales Value by Type (%), 2023 VS 2030
 Figure 39. Japan Healthcare Contract Research Organization Sales Value by Application (%), 2023 VS 2030
 Figure 40. South Korea Healthcare Contract Research Organization Sales Value, (2019-2030) & (US$ Million)
 Figure 41. South Korea Healthcare Contract Research Organization Sales Value by Type (%), 2023 VS 2030
 Figure 42. South Korea Healthcare Contract Research Organization Sales Value by Application (%), 2023 VS 2030
 Figure 43. Southeast Asia Healthcare Contract Research Organization Sales Value, (2019-2030) & (US$ Million)
 Figure 44. Southeast Asia Healthcare Contract Research Organization Sales Value by Type (%), 2023 VS 2030
 Figure 45. Southeast Asia Healthcare Contract Research Organization Sales Value by Application (%), 2023 VS 2030
 Figure 46. India Healthcare Contract Research Organization Sales Value, (2019-2030) & (US$ Million)
 Figure 47. India Healthcare Contract Research Organization Sales Value by Type (%), 2023 VS 2030
 Figure 48. India Healthcare Contract Research Organization Sales Value by Application (%), 2023 VS 2030
 Figure 49. Healthcare Contract Research Organization Industrial Chain
 Figure 50. Healthcare Contract Research Organization Manufacturing Cost Structure
 Figure 51. Channels of Distribution (Direct Sales, and Distribution)
 Figure 52. Bottom-up and Top-down Approaches for This Report
 Figure 53. Data Triangulation
 Figure 54. Key Executives Interviewed

Description

The global market for Healthcare Contract Research Organization was estimated to be worth US$ 71460 million in 2023 and is forecast to a readjusted size of US$ 126620 million by 2030 with a CAGR of 8.6% during the forecast period 2024-2030.

A Contract Research Organization (CRO) is a company that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of outsourced research services. These services can range across various stages of the drug development process, including preclinical research, clinical trials, regulatory affairs, data management, and market analysis. CROs offer their expertise to help these industries develop and commercialize new drugs, therapies, and medical devices, often by managing or conducting the clinical trials that are required by regulatory agencies before a product can enter the market.

The Contract Research Organization (CRO) market has been growing and evolving rapidly, influenced by changes in the pharmaceutical, biotech, and medical device industries. Here are the key trends shaping the CRO market:
Increased Outsourcing in Biopharma and Medical Device Sectors
Growing Demand for R&D Outsourcing: Pharmaceutical and biotech companies are increasingly outsourcing clinical trials and drug development tasks to CROs to reduce costs, speed up timelines, and gain access to specialized expertise.

Small and Mid-Sized Enterprises (SMEs): Smaller companies with limited resources, especially in the biotech sector, are using CRO services to manage their clinical and preclinical studies, focusing on their core research areas.

Decentralized Clinical Trials (DCTs): The COVID-19 pandemic accelerated the adoption of remote and decentralized trials, where CROs use technology like wearable devices, telemedicine, and remote monitoring to reduce patient site visits.

Hybrid Trials: Many CROs are now supporting hybrid trial models, where some trial elements are conducted on-site and others remotely, allowing greater flexibility in patient recruitment and retention.

Orphan Drugs and Personalized Medicine: CROs are focusing more on rare disease trials and personalized medicine, which require niche expertise and innovative trial designs. This focus is driven by advances in genetic and biomarker testing, which allow for more targeted treatment approaches.

Oncology: As one of the most active areas of clinical research, oncology continues to drive demand for CROs due to the complexity and duration of cancer trials and the need for innovative approaches in recruitment and data analysis.

Artificial Intelligence (AI) and Machine Learning (ML): CROs are leveraging AI and ML for predictive analytics, patient recruitment, and data analysis, enhancing efficiency and accuracy in clinical trials.

Digital Health Tools and Wearable Technology: Real-time data collection from wearables and other digital health devices allows CROs to monitor patient health remotely and continuously, reducing reliance on site visits and improving data quality.

The Healthcare Contract Research Organization market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Healthcare Contract Research Organization.

Market Segmentation